Back to Endocrinology
Endocrinologyv2016Evidence-Based

C-Peptide to Glucose Ratio

Assesses beta cell secretory function in patients with diabetes/pre-diabetes. The C-peptide to glucose ratio (CGR) is a simple marker that helps evaluate endogenous insulin secretion capacity and can guide diabetes management decisions.

Clinical Input Parameters

ng/mL
Range: 0.01 — 50 ng/mL
mg/dL
Range: 10 — 1000 mg/dL
Clinical Assessment
Awaiting Parameters
c peptide glucose ratio
—ratio
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The C-Peptide to Glucose Ratio is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within endocrinology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

C-peptide to glucose ratio = serum C-peptide level (ng/mL) / plasma glucose level (mg/dL) × 100

Clinical Pearls & Practice Notes

  • C-peptide is co-secreted with insulin in equimolar amounts from pancreatic beta cells
  • Unlike insulin, C-peptide is not significantly extracted by the liver and has a longer half-life
  • Best measured in the postprandial state (1-2 hours after meal) for optimal assessment
  • Not recommended for patients with chronic kidney disease as C-peptide clearance is reduced
  • Can help distinguish between Type 1 and Type 2 diabetes in unclear cases
  • Useful for monitoring disease progression and adjusting therapy in Type 2 diabetes
  • May help identify patients who can transition from insulin to oral agents

Evidence & Literature Citations

  1. Saisho Y. Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes. Int J Mol Sci. 2016 May 6;17(5):744. doi: 10.3390/ijms17050744.
  2. Fritsche A, Heni M, Peter A, Stefan N, Häring HU, Wagner R. Different Effects of Lifestyle Intervention in High- and Low-Insulin Secretors. Diabetes Care. 2023 Feb 1;46(2):290-297. doi: 10.2337/dc22-1523.
  3. Iwao T, Sakata N, Takeuchi T, Nishimura K, Ohtake S, Akaiwa Y, Kawamura I, Ito A, Yoshida A. Postprandial Serum C-Peptide to Plasma Glucose Ratio Predicts Future Insulin Therapy in Patients with Type 2 Diabetes: A 10-Year Prospective Cohort Study. J Diabetes Investig. 2021 Jan;12(1):68-75. doi: 10.1111/jdi.13304.

Score Interpretation Ranges

Insulin Secretion Deficit0 – 2 pts

Severe beta cell dysfunction

Impaired Insulin Secretion2 – 5 pts

Moderate beta cell dysfunction

Preserved Insulin Secretion5 – 999 pts

Adequate beta cell function

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.